Clinical Trial Update: Comparison of 2 Different Indomethacin Dosing Protocols to Treat Infants Delivered at <28 Weeks Gestation With a Persistent Patent Ductus Arteriosus [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial compares two dosing protocols of indomethacin to treat patent ductus arteriosus in infants born at less than 28 weeks gestation; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Patent Ductus Arteriosus

Drugs mentioned

• INDOMETHACIN (INDOMETHACIN)

Snippet

Sponsor: University of California, San Francisco | Conditions: Patent Ductus Arteriosus | Phase 2 | Status: COMPLETED